Clinical Trials Directory

Trials / Unknown

UnknownNCT04273438

Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Queen's University, Belfast · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To validate a new virtual reality (VR) based visual field test against the gold standard clinical perimetry test (Humphrey Visual field test 24-2).

Detailed description

Perimetry (or visual field testing) is a vision test used to evaluate a patient's peripheral vision. It involves a patient fixating on a central target and pressing a button when they see a spot of light in their peripheral vision. It is an important way of deciding whether Glaucoma is progressing or not. Next generation virtual reality (VR) technologies offer an exciting new way of conducting perimetry in either a clinical or home environment, allowing more affordable and more frequent monitoring of disease progression in glaucoma, and an easier and more comfortable experience for patients. The investigators propose to create a perimetry test using a commercially available head mounted display for VR, and to assess its accuracy in glaucoma patients in relation to standard automated perimetry.

Conditions

Interventions

TypeNameDescription
DEVICEVisual field testing using Oculus Rift and Humphrey Visual Field PerimeterGlaucoma patients at Queen's University, Belfast, will be invited to undergo both Visual field testing using the Oculus Rift and the gold-standard Humphrey 24-2 (Carl Zeiss Meditec, Dublin, CA) at two visits, and evaluating consistency for detecting visual field impairments.
DEVICEVisual Field Testing using HUmphrey 24-3 PerimeterGlaucoma patients at Queen's University, Belfast, will be invited to undergo both Visual field testing using the Oculus Rift and the gold-standard Humphrey 24-2 (Carl Zeiss Meditec, Dublin, CA) at two visits, and evaluating consistency for detecting visual field impairments.

Timeline

Start date
2018-10-01
Primary completion
2020-09-30
Completion
2020-12-31
First posted
2020-02-18
Last updated
2020-02-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04273438. Inclusion in this directory is not an endorsement.